. A few lipid-insoluble substances, such as glucose ( 11) and some amino acids (30), also pass the BBB freely when present in blood in low concentrations.
It is the characterization of BBB permeability to substances with relatively high uptake rates to which this series of brain uptake studies is directed.
Previous radioisotopic studies of BBB permeability have employed a radiolabeled test substance introduced intraperitoneally or intravenously. Some minutes to hours later the brain concentration is measured and related either to the terminal blood plasma concentration or the injected dose. A major problem is the lack of a suitable reference with which to compare brain uptake. Ideally, a constant blood concentration is maintained during the equilibration period.
Systemic administration with prolonged presence of the test substance in the body commonly results in metabolism of the tracer either before or after entering brain. The novel methodology used in the present investigations (29) circumvents most of the disadvantages of methods requiring systemic administration, Results presented are of the measurements of brain uptake of a number of radiolabeled substances during their first microcirculatory passage after rapid injection into rat common carotid artery. The test substance, 14C-labeled, is mixed with tritiated water (3HOH) and injected. The rat is decapitated 15 set later. The amount of test substance remaining in brain at that time is expressed as a percentage of the "HOH present (29) . A large number of substances related to brain metabolism have been examined in this laboratory by this method. These include amino acids, biogenic amines, hexoses, and metabolically inert polar compounds of various molecular weights. Previous studies from other laboratories have described brain uptake of a great variety of test substances after systemic administration.
Various routes of isotope administration and calculation have been used. The present study compares the brain uptake of 28 common amino acids, 13 common biogenic amines, and seven hexoses using a single method, and defmes the saturation characteristics of the BBB penetration by some of these substances.
METHOD
The general methodology has been described elsewhere (29) The nutritional amino acids shown in Table 2 were also studied using normal rat serum to make up 90% of the injected solution rather than Elliott's B solution (Fig. 2) . The latter solution has no organic constituent other than 5-mM D-glucose. Serum was obtained from arterial blood collected following decapitation of pentobarbital anesthetized Wistar rats. The brain uptake of 14C amino acids in the presence of serum should be more representative of the rate of bloodbrain exchange in the intact animal than that observed using the inorganic diluent. A reduction in BUI using a test substance in serum would suggest either that the tracer is partially bound in a nondialyzable form to serum proteins or that substances in serum are competing with the tracer for carrier-mediated transport sites in the BBB. The effects of using serum as a diluent are shown in Fig. 2 . All of the amino acids except proline, aspartate, glutamate, and glycine show reductions to ZO-50% of the BUI observed with inorganic diluent. The uptakes of proline, aspartate, glutamate, and gIycine are below the measurable limits of the method using either diluent.
Amino acid cross-inhibition. The unlabeled amino acids (Lenantiomorphs) in the left column of Table 3 were injected at a 4-mM concentration to measure their ability to inhibit brain uptake of the seven 14C-labeled species indicated at the head of the vertical columns. The values in Table 3 (Fig. 3) . Inhibition of L-methionine-35S uptake was also studied by adding unlabeled D-methionine in concentrations up to 10 xn~ ( BUI by one-half (K,) is approximately 0.5 mM and for n-methionine about 1 mM. In addition to studies using the Elliott's B solution a series of self-inhibition studies were conducted using normal rat serum to make up 90% of the volume of the injected solu- The BUI of the 13 amines studied are shown in Table 4 . Most are near the lower limit of measurability.
Acetylcholine is included and also exhibits a barely measurable uptake.
Hexoses
Uptake at low injected concentrutions. The hexoses shown in Table 5 were injected with no added unlabeled substance. 
Brain Uptake Index MM tion. This mixture contained unlabeled methionine in concentrations ranging 0.015-5 mM in addition to the free amino acids present naturally in the rat serum. Three animals were studied adding no unlabeled methionine but using rat serum which had been dialyzed for several hours against a large volume of Elliott's B solution to remove small organic molecules. The BUI using this dialyzed serum diluent was (32.2) not significantly (P < .6) different from that found with an inorganic diluent (33.9). Using 90% undialyzed serum as a diluent shifts the Lmethionine WI saturation curve to the left about 1 mM.
~---_------. 5 mM reduced the BUI to 22.5. The BUI in the presence of 80-mM cold D-glucose was 9. The anomeric forms of the unlabeled D-glucose and the D-glucoseJ4C used in this part of the study were unstated by the manufacturers. Unlabeled D-glucoses of known anomerit form (Calbiochem) were studied as competitors of D-glucose-14C uptake. Two g roups of animals were injected with D-glucose-14C with 20-mM cold a-D-glucose (three animals) and cold P-D-glucose (three animals). Both of these cold D-glucose competitive mixtures were injected within 15 min of dissolving to minimize spontaneous mutarotation to the racemic alpha-beta form. This study was undertaken to assess any difference in BBB carrier affinity for these anomers of D-glucose. No significant difference was noted in the ability of these two anomers to inhibit D-glucose uptake (Table 6 ).
Cross-inhibition of D-gIucoseJ4C uptake. The hexoses in Table   5 were included in nonradioactive form in the injected solution of D-glucoseJ4C at concentrations of 5, 10, 20, or 40 mM (Table 6 ) I There is a good correlation between the degree of suppression of D-glucose -14C uptake by these unlabeled substances alid their uptake when injected radiolabeled.
Those hexoses (such as Z-deoxy-D-glucose) which have a high BUI are effective at relatively low concentrations at inhibiting the uptake of D-glucoseJ4C. Figure 5 is a plot of the BUI of each of these radiolabeled test substances, shown in Table 5 , vs. l/Km for that substance when injected as an unlabeled compound.
Km. in this instance is the millimolar concentration required to reduce the BUI of D-glucoseJ4C to one-half its uninhibited BUI of 33. These values for K, were estichange or the loss from brain tissue of products of metabolism of the test substance after exchange. This assures the BBB exchange results are those of the injected substance.
The high rate of injection and consequent minimal mixing of the injected bolus with blood allows the modification of the co mposition of the injected mixture to include known concentrations of potentia 1lY competitive unl .abeled substances with ass urance that the solution arrives in the brain microcirculation with a composition not greatly diflering from that injected.
The minimal mixing with blood prevents removal from free solution by binding of the teins. It also pre vents co mpetit tes t substance to plasma prowith the test substance for ion BBB transport -carrier sites by substances in free solution in blood plasma. Since very little of the injected test substance mated by interpolation of the scattered various concentrations shown in Table 2 .
BUT values at remains in brain blood, a blood content is required. Carotid-arterial injection minimal correction for resid ual delivers a large fraction of the Unlabeled L-arginine (10 mM) and 2%mM unlabeled L-phenylalanine were also competed against D-g1ucoseJ4C using three animals for each compound and no inhibition was noted ( Elliott's B solution was used because its electrolyte composition approximates blood plasma. The pH of this solution varied from 7.5 to 8.5, probably due to escape of CO2 . To obtain a more constant pH, the diluent was changed in later studies to Ringer solution buffered to pH 7.56 with 4-mM HEPES, Good's buffer ( 17). Duplicate studies of phenylalanine and tyrosine uptake revealed no significant dialerences in BUI using these two diluents*
The temperature of the injected solution in these studies was 22-25 C (room temperature).
At the microcirculatory site of exchan .ge with tissue the temperature presumably was intermediate be tween this and brain temperature. To measure the effect of temperature of the injected solution on D-glucoseJ4C uptake, three groups of three rats each were studied at 2, 20, and 37 C. The BUI of these groups were 30.4, 3 1.2, and 30+7, respectively, indicating independence of BUI and injection temperatures.
The penetration of cell membranes by solutes not having afinity for specific transport-carrier sites is largely a function of the relative affinity of the test substance for water and the proteolipid of the cell membrane. This could be determined by an in vitro oil-water partition coefhcient measurement. The in vivo carotid-injection method employed here might be thought of as a form of partition coefficient study. This in vivo method is simpler to perform and is free of many artifacts inherent in in vitro partition coefficient studies
DISCUSSION

Methodology
The method employed here to measure blood-brain exchange rates uses 3HOH as a reference with which the 14C-labeled test substance is compared. The BUI of these inert substances is 1.4-2.3 and this could be considered the base line or background level with which all test substances might be compared.
The BUI values presented here have not been corrected for this residual but such a correction probably would offer a more precise measurement of the test substance which actually passed through the BBB.
Amino Acid Uptake
A considerable range of BUI is observed. When arranged in descending order of uptake ( Fig. 7) it was noted that those amino acids nutritionally essential to the rat enter brain more freely than nonessentials (30). Although tyrosine is considered nonessential to the rat (34) it enters brain freely. The high uptake of tyrosine noted in this study is commensurate with previous brain uptake studies of systemically administered tyrosine (9). Since phenylalanine hydroxylase is not present in brain ( 19), tyrosine presumably must enter through BBB (34) and is thus essential in the sense that it probably cannot be synthesized by brain. The individual amino acid uptakes are unrelated to molecular size or other obvious physical or chemical parameters.
It has been suggested that the low BUI of several of the nutritional amino acids may be correlated with the ability of brain to synthesize them from a glucose substrate (34).
The free entry of many radiolabeled amino acids into brain after systemic administration has been reported (2, 24). Using that route of administration, equilibration halftimes between brain and plasma of some minutes have been calculated (23). The present work suggests the rate of equilibration is much faster than this for many amino acids, particularly the essential amino acids, since equilibrations up to about one-half that of 3HOH are achieved in the l-2 set most of the test substance remains in the brain microcirculation.
The low BUI of y-aminobutyric acid (GABA), glutamate, aspartate, and glycine may be related to their putative roles as central transmitter substances since the BBB permeability to all transmitter substances probably is low. The appreciable uptake of thyroxine is compatible with the observation that cerebrospinal fluid thyroxine levels approximate plasma levels of nonprotein bound thyroxine (20). Although nearly all plasma thyroxine is bound, the small unbound fraction evidently freely equilibrates across BBB. Because the labeled thyroxine in the rapidly injected bolus is largely isolated from plasma protein, the BUI found here probably is representative of the rate of equilibration of the free plasma fraction.
Of the two nonmetabolized amino acids studied, cycloleucine passes the BBB as freely as some of the nutritionally essential amino acids but AAIBA does not. This suggests that subsequent metabolism of the test substance is not essential to its free BBB penetration.
The unequal uptake of L-and n-enantiomorphs of tyrosine (Table  2 ) and the unequal inhibitory effects of unlabeled Land D-methionine on methionine-35S uptake (Fig. 3) indicate an incomplete stereospecificity of their BBI3 transport.
A similar incomplete stereospecificity of brain uptake of phenylalanine, leucine, and lysine has been demonstrated (25) after intraperitoneal injection. Clearly the L-enantiomorphs have a greater affinity for the BBl3 amino acid carrier system, but the D-enantiomorphs exhibit an appreciable, although reduced, affinity. The stereospecificity shown for these two amino acids is much less complete than shown for D-and L-glucose using the same technique.
There is very efficient uptake of n-glucose, but no measurable uptake of the L-enantiomorph. The relative uptakes of the various amino acids are quite unlike the relative activity of transport by the inverted hamster small intestine.
Proline, threonine, alanine, and glycine are most actively transported by the intestine (40), whereas in the present study they exhibit unmeasurably low brain uptakes.
The relative uptakes found here are also quite different from the uptake by tissue slices in a medium containing radiolabeled amino acids. Glycine, glutamic, alanine, and proline, for example, are very actively concentrated by brain tissue when exposed in this manner (25) but have essentially no uptake by the present method. When relating the present studies of brain uptake of various labeled substances, caution must be exercised to exclude previous studies in which brain tissue has been exposed directly to the test substance either in vivo by ventricular injection or in vitro with introduction into tissue slice supportive media. In these instances the test substance can diEuse directly into the extracellular fluid environment of the nervous system cells and need not traverse the restrictive walls of brain capillaries as in the present studies. The BUI, as determined by the presently employed carotid-injection method, probably represents a product of at least two factors such as freedom of BBB penetration and the distribution space of the test substance in brain once BBB has been penetrated.
The latter factor probably corre-lates with direct tissue uptake by tissue slices or by intact brain after ventricular injection. The relative rates of uptake observed here approximate those observed for red blood cells in vitro (39).
Serum competition. The lower BUI observed for most of the amino acids using a serum vehicle suggests either removal of the test substance from free solution by plasma protein binding or competition for BBB carrier sites by the amino acids normally present in rat serum* Using dialyzed serum, the restoration of the methionine BUI using a serum diluent to level seen with Elliott's solution suggests plasma protein binding (at least for this amino acid) is not an important factor in the reduced methionine uptake observed using a serum diluent. The observation that dialyzed serum used as a diluent results in nearly the same uptake as with an inorganic diluent suggests that the reduction of methionine BUI in the presence of serum is due to the presence of some dialyzable solute competitive with the methionineJ4C for BBB transport; probably amino acids competitive with methionine.
The marked BUI reduction for all of the amino acids when using a serum diluent suggests that the BBB carrier system for many of the amino acids is near saturation in the presence of normal serum levels of amino acids.
The reduction of exchange rates noted in these studies in the presence of serum may explain some of the difference in exchange rates noted when labeled amino acids are administered systemically (23) as against rapid arterial injection of solution containing essentially no unlabeled amino acids reported here. When administered systemically the radiolabeled amino acid species must compete with serum amino acids for BBB carrier sites When administered rapidly intraarterially there probably is no such competition during the brief period of exchange and the radiolabeled species has relatively free access to these carrier sites.
Because of a lack of competition with serum solutes for BBB carrier sites or because of combination with serum proteins, rapid arterial injection probably will result in an exaggerated uptake of many test substances relative to that measured after systemic administration.
Cross-inhibition studies. To study the ability of each of the nutritional amino acids to cross-inhibit each of the others would require a prohibitive number of experiments. To restrict this number, the seven labeled amino acids of Table  3 were chosen from various levels down the list of diminishing uptake (Table 2) .
The reduction of the radiolabeled amino acid BUT to more than five SD below the uncompeted mean amino acid BUI has a significance of P < .OOl. Using this criterion, significant cross-inhibition occurs between all of the high BUI amino acids studied (more than 10 % BUI in Table 2 ) with the exception of arginine, lysine, and histidine which do not cross-inhibit with the others. Unlabeled arginine, lysine, and histidine all inhibit arginine uptake. Unlabeled tyrosine inhibits arginine uptake to a slight but significant degree. Cycloleucine evidently enters brain via the same carrier mechanism as phenylalanine since 4-mM phenylalanine inhibits its uptake whereas 4-rnM arginine does not.
Amino acids which have a high BUI, such as phenylalanine, presumably have a greater affinity for their BBB carrier system than those exhibiting a low BUI such as alanine.
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This is consistent with the data in Table 3 indicating that, in general, high BUI amino acids are effective cross-inhibitors, but low BUI amino acids are not. Because the uptake of the amino acids toward the lower end of Table 2 is so low and the SD so large, a five SD reduction is unlikely. Thus, the amino acids near the lower end of Table 2 are not accessible to this mode of analysis. Separate carrier systems may facilitate their minimal passage through BBB. Mefhionine self-inhibition.
In the presence of increasing concentrations of unlabeled methionine the methionine H-J1 falls rapidly until the injected methionine reaches about 2 mM and then falls very gradually at higher concentrations. At 40-mM injected methionine concentration the BUI is 3.26; an elevation about the BU1 of urea and mannitol of doubtful significance. These data (Fig. 3) suggest methionine exchange through BBB is, within the limits of the present method, completely saturable.
Am inas
The putative transmitter substances dopamine, norepinephrine, epinephrine, 5-hydroxytryptamine, and histamine all exhibit very low uptakes. This is in agreement with the very low uptakes by brain after systemic administration described for norepinephrine (3 7), dopamine (16), 5-hydroxytryptamine (3, 36), and histamine (35). The relatively high uptake (BUI 12.5) of tryptamine is in general agreement with Green and Sawyer (18), although precise comparison with the present study is impossible because the methodologies employed are so different. Beta-phenethylamine has the greatest uptake of all of the amines studied. Substituting one methoxy group in the para position has a minimal effect on BBB penetration (Fig. 8) . For each value n = 3.
technique. This probably relates to the hydrogen bonding of the hydroxyl groups to water.
Decarboxylating an amino acid results in a marked reduction of uptake for the resulting amine in the case of tyrosine to tyramine, Dopa to dopamine, 5-hydroxytryptophane to 5-hydroxytryptamine, histidine to histamine, and tryptophane to tryptamineGamma amidation of glutamate results in a greater uptake for glutamine.
To assess whether or not dopamine uptake is significantly above that of neutral polar test substances of similar molecular weight it was compared with mannitol (mol wt 180) as a test substance. The doparnine uptake is greater (3.85) than mannitol(1.94) with P < .OOl indicating that it is above the lower level of measurability.
The putative transmitter precursors 5-hydroxytryptoyhane, Dopa, and histidine all show substantially higher rates of uptake when studied with the same technique. These findings, together with the observations of low uptakes of GABA, glycine, aspartate, and glutamate are consistent with the generalization that precursors of central nervous system transmitters have high rates of blood-brain exchange whereas transmitter substances have low rates. If this generalization is correct the search for currently unrecognized transmitters might be assisted by concentrating research efforts on low-uptake test substances as measured by the present technique.
The very restricted I3I3B penetration of all putative transmitters studied here suggests a function of BBB may be to conserve and localize brain extracellular transmitter concentrations.
The BBB ordinarily is considered to be a mechanism for excluding plasma solutes from brain extracellular fluid but restriction of passage from brain to plasma may also be a major aspect of BBB teleology.
Hexoses
Hexose-uptake at lora, injected concentrations. The uptakes of the hexoses in Table 5 are in general agreement with previous studies of BBB penetration using a variety of methodologies ( 1, 5, 7, 22, 27, 3 1) . The particularly high 2-deoxy-D-glucose uptake is in agreement with Fishman's ( 15) observation that this substance equilibrates more rapidly between blood and CSF than does n-glucose. A very low rate of BBB penetration by D-fructose was also noted by Crone (11) and by Fishman ( 15).
The complete stereospecificity of the uptake of D-and L-glucose is quite different from the incomplete stereospecificity for L-and D-tyrosine uptake and L-and D-methionine reported above.
There probably is no metabolism of 3-O-methyl-o-glucose in brain or elsewhere (4, 28), yet this substance freely penetrates BBB. Th" is suggests subsequent metabolism by brain is not a requirement of carrier-mediated BBB transport. This observation parallels the observation that cycloleucine, a nonmetabolized amino acid, also freely penetrates BBB by a saturable mechanism. The 2-deoxy-D-glucose is partially metabolizable since it can be phosphorylated to 2-deoxy-nglucose-6-phosphate (2 l), whereas 3-O-methyl-D-glucose is compIetely nonmetabolizable. 
